SEC Form 4 · accession 0001209191-15-079802
Arcadia Biosciences, Inc. · RKDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vic C. Knauf
Officer — Chief Scientific Officer
Period of report
Nov 11, 2015
Accepted (ET)
Nov 12, 2015 · 5:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001469443
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 11, 2015 | M | 20,000 | $0.44 | A | 51,661 | D | |
| Common StockF2 | Nov 11, 2015 | S | 4,527 | $2.9138 | D | 47,134 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $0.44 | Nov 11, 2015 | M | 20,000 | D | — | Dec 31, 2015 | Common Stock | 20,000 | 0 | D |
Explanation of responses
- F1The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan (the "Plan"), adopted by the Reporting Person effective June 12, 2015.
- F2This transaction was executed in multiple trades at prices ranging from $2.82 to $2.9224. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3The option is fully exercisable as of the date hereof.